Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Durrant Cameron Create: Alert

All | News | Filings
Date FiledTypeDescription
07/29/2022 4 Durrant Cameron (CEO) has filed a Form 4 on HUMANIGEN, INC
Txns: Granted 808,906 options to buy @ $0.38, valued at $307.4k
03/04/2022 4 Durrant Cameron (CEO) has filed a Form 4 on HUMANIGEN, INC
Txns: Bought 40,000 shares @ $2.34, valued at $93.6k
01/14/2022 4 Durrant Cameron (CEO) has filed a Form 4 on HUMANIGEN, INC
Txns: Granted 84,385 options to buy @ $2.99, valued at $252.3k
01/04/2022 4 Durrant Cameron (CEO) has filed a Form 4 on HUMANIGEN, INC
Txns: Granted 76,000 options to buy @ $3.72, valued at $282.7k
11/26/2021 4 Durrant Cameron (CEO) has filed a Form 4 on HUMANIGEN, INC
Txns: Disposed/sold 17,660 options to buy @ $5.93, valued at $104.7k
10/04/2021 4 Durrant Cameron (CEO) has filed a Form 4 on HUMANIGEN, INC
Txns: Granted 17,660 options to buy @ $5.93, valued at $104.7k
06/16/2021 4 Durrant Cameron (CEO) has filed a Form 4 on HUMANIGEN, INC
Txns: Gifted 111,441 shares @ $0
Gifted 111,441 shares @ $0
Sold 26,441 shares @ $20.6, valued at $544.7k
Sold 5,094 shares @ $21.14, valued at $107.7k
Sold 49,906 shares @ $20.61, valued at $1M
03/15/2021 4 Durrant Cameron (CEO) has filed a Form 4 on HUMANIGEN, INC
Txns: Granted 652,640 options to buy @ $16.07, valued at $10.5M
10/07/2020 4 Durrant Cameron (CEO) has filed a Form 4 on HUMANIGEN, INC
Txns: Granted 82,622 options to buy @ $12.14, valued at $1M
05/21/2020 4 Durrant Cameron (CEO) has filed a Form 4 on HUMANIGEN, INC
Txns: Granted 250,000 options to buy @ $0.86, valued at $215k
01/29/2020 4 Durrant Cameron (CEO) has filed a Form 4 on HUMANIGEN, INC
Txns: Granted 318,103 options to buy @ $0.4, valued at $127.2k
06/05/2019 4 Durrant Cameron (CEO) has filed a Form 4 on HUMANIGEN, INC
Txns: Granted 8,000 shares @ $1.25, valued at $10k
05/31/2019 4 Durrant Cameron (CEO) has filed a Form 4 on HUMANIGEN, INC
Txns: Acquired 235,624 shares @ $0
04/25/2019 4 Durrant Cameron (CEO) has filed a Form 4 on HUMANIGEN, INC
Txns: Granted 75,000 shares @ $0.665, valued at $49.9k
Exercised 75,000 options to buy @ $0.665, valued at $49.9k
03/11/2019 4 Durrant Cameron (CEO) has filed a Form 4 on HUMANIGEN, INC
Txns: Granted 75,000 shares @ $0.665, valued at $49.9k
Exercised 75,000 options to buy @ $0.665, valued at $49.9k
01/28/2019 4 Durrant Cameron (CEO) has filed a Form 4 on HUMANIGEN, INC
Txns: Granted 142,857 options to buy @ $0.84, valued at $120k
12/14/2018 4 Durrant Cameron (CEO) has filed a Form 4 on HUMANIGEN, INC
Txns: Granted 2,000 shares @ $0.8219, valued at $1.6k
Granted 4,000 shares @ $0.816, valued at $3.3k
12/12/2018 4 Durrant Cameron (CEO) has filed a Form 4 on HUMANIGEN, INC
Txns: Granted 2,500 shares @ $0.75, valued at $1.9k
Granted 2,500 shares @ $0.757, valued at $1.9k
12/10/2018 4 Durrant Cameron (CEO) has filed a Form 4 on HUMANIGEN, INC
Txns: Granted 10,000 shares @ $0.732, valued at $7.3k
Granted 7,000 shares @ $0.739, valued at $5.2k
03/13/2018 4 Durrant Cameron (CEO) has filed a Form 4 on HUMANIGEN, INC
Txns: Granted 7,466,749 options to buy @ $0.665, valued at $5M
01/27/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
09/15/2016 4 Durrant Cameron (CEO) has filed a Form 4 on KALOBIOS PHARMACEUTICALS INC
Txns: Granted 1,043,022 options to buy @ $3.38, valued at $3.5M
07/05/2016 4 Durrant Cameron (Chairman and CEO) has filed a Form 4 on KALOBIOS PHARMACEUTICALS INC
Txns: Granted 135,583 shares @ $0
06/03/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
02/02/2016 4 Durrant Cameron (Director) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC
Txns: Granted 40,000 options @ $0.53, valued at $21.2k
01/12/2015 4 Durrant Cameron (Director) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC
Txns: Granted 50,000 options @ $2.2, valued at $110k
12/03/2014 4 Durrant Cameron (Director) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC
Txns: Bought 4,000 shares @ $2.5, valued at $10k
Bought 1,000 warrants @ $3.75, valued at $3.8k
07/14/2014 4 Durrant Cameron (Director) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC
Txns: Granted 50,000 options to buy @ $3.05, valued at $152.5k
04/08/2013 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
04/08/2013 4 Durrant Cameron (President, CEO, CFO, Treasurer) has filed a Form 4 on PediatRx Inc.
Txns: Bought 4,250,000 shares @ $0.012, valued at $51k
03/13/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
03/13/2013 3 Durrant Cameron (President, CEO of ECR Pharm.) has filed a Form 3 on HI TECH PHARMACAL CO INC
02/11/2011 4 Durrant Cameron (President, CEO) has filed a Form 4 on PediatRx Inc.
02/10/2011 4 Durrant Cameron (Executive Chairman) has filed a Form 4 on ANAVEX LIFE SCIENCES CORP.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy